Kantarjian H - Search Results

1

Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts.

Short NJ, Jabbour E, Albitar M, de Lima M, Gore L, Jorgensen J, Logan AC, Park J, Ravandi F, Shah B, Radich J, Kantarjian H. Short NJ, et al. Among authors: kantarjian h. Am J Hematol. 2019 Feb;94(2):257-265. doi: 10.1002/ajh.25338. Epub 2018 Nov 26. Am J Hematol. 2019. PMID: 30394566 Free PMC article. Review.

2

Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy.

Anaissie E, Bodey GP, Kantarjian H, David C, Barnett K, Bow E, Defelice R, Downs N, File T, Karam G, et al. Anaissie E, et al. Among authors: kantarjian h. Am J Med. 1991 Aug;91(2):142-50. doi: 10.1016/0002-9343(91)90006-j. Am J Med. 1991. PMID: 1867240 Clinical Trial.

3

What is the contribution of molecular studies to the diagnosis of BCR-ABL-positive disease in adult acute leukemia?

Kantarjian H, Talpaz M, Estey E, Ku S, Kurzrock R. Kantarjian H, et al. Am J Med. 1994 Feb;96(2):133-8. doi: 10.1016/0002-9343(94)90133-3. Am J Med. 1994. PMID: 8109597

4

Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.

Kurzrock R, Kantarjian H, Wetzler M, Estrov Z, Estey E, Troutman-Worden K, Gutterman JU, Talpaz M. Kurzrock R, et al. Among authors: kantarjian h. Exp Hematol. 1993 Jan;21(1):80-5. Exp Hematol. 1993. PMID: 8417962

5

Acute lymphoblastic leukemia with myeloperoxidase activity.

Wright S, Chucrallah A, Chong YY, Kantarjian H, Keating M, Albitar M. Wright S, et al. Among authors: kantarjian h. Am J Hematol. 1996 Feb;51(2):147-51. doi: 10.1002/(SICI)1096-8652(199602)51:2<147::AID-AJH9>3.0.CO;2-Y. Am J Hematol. 1996. PMID: 8579056 Free article.

6

HyperCVAD for VAD-resistant multiple myeloma.

Dimopoulos MA, Weber D, Kantarjian H, Delasalle KB, Alexanian R. Dimopoulos MA, et al. Among authors: kantarjian h. Am J Hematol. 1996 Jun;52(2):77-81. doi: 10.1002/(SICI)1096-8652(199606)52:2<77::AID-AJH2>3.0.CO;2-2. Am J Hematol. 1996. PMID: 8638645 Free article. Clinical Trial.

7

Chronic myelogenous leukemia: a review.

Cortes JE, Talpaz M, Kantarjian H. Cortes JE, et al. Among authors: kantarjian h. Am J Med. 1996 May;100(5):555-70. doi: 10.1016/s0002-9343(96)00061-7. Am J Med. 1996. PMID: 8644769 Review.

8

Acute lymphocytic leukemia: a comprehensive review with emphasis on biology and therapy.

Cortes JE, Kantarjian H, Freireich EJ. Cortes JE, et al. Among authors: kantarjian h. Cancer Treat Res. 1996;84:291-323. doi: 10.1007/978-1-4613-1261-1_13. Cancer Treat Res. 1996. PMID: 8724635 Review. No abstract available.

9

Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia.

Beran M, Kantarjian H, O'Brien S, Koller C, al-Bitar M, Arbuck S, Pierce S, Moore M, Abbruzzese JL, Andreeff M, Keating M, Estey E. Beran M, et al. Among authors: kantarjian h. Blood. 1996 Oct 1;88(7):2473-9. Blood. 1996. PMID: 8839838 Free article. Clinical Trial.

10

Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl.

Sarris A, Cortes J, Kantarjian H, Pierce S, Smith T, Keating M, Koller C, Kornblau S, O'Brien S, Andreeff M. Sarris A, et al. Among authors: kantarjian h. Leuk Lymphoma. 1996 Mar;21(1-2):85-92. doi: 10.3109/10428199609067584. Leuk Lymphoma. 1996. PMID: 8907274

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,548 results

Search Page

Filters